Goeltz II Robert C. - Insider Non-Derivative Transactions at Arcus Biosciences, Inc. (RCUS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 17, 2025, Goeltz II Robert C.'s relationship to Arcus Biosciences, Inc. (RCUS) is Officer (Chief Financial Officer), and currently has 74,476 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RCUS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Goeltz II Robert C. - Insider Non-Derivative Transactions of RCUS Common Stock

Goeltz II Robert C. - Insider Non-Derivative Transactions at RCUS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 18, 2025	Sell -- (Common Stock)	5960	22.16	74476
Dec 17, 2025	Sell -- (Common Stock)	6702	21.88	80436
Nov 27, 2025	Sell -- (Common Stock)	5000	25	87138
Oct 29, 2025	Sell -- (Common Stock)	5000	20	92138
Jan 24, 2025	Acquisition -- (Common Stock)	37000	0	97138
Jan 1, 2025	Sell -- (Common Stock)	3594	15	60138
Dec 16, 2024	F -- (Common Stock)	10099	16.08	63732
Jan 24, 2024	Acquisition -- (Common Stock)	21300	0	73131
Jan 24, 2024	Acquisition -- (Common Stock)	22000	0	73831
Jan 3, 2024	Sell -- (Common Stock)	2004	20	51831
Dec 20, 2023	Disposition -- (Common Stock)	2808	18.09	53835
Dec 19, 2023	Disposition -- (Common Stock)	2749	17.74	56643
Jun 8, 2023	Sell -- (Common Stock)	4049	20.04	59392
Jan 24, 2023	Acquisition -- (Common Stock)	34000	0	63441